Arora Neeraj K, Finney Rutten Lila J, Gustafson David H, Moser Richard, Hawkins Robert P
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892-7344, USA.
Psychooncology. 2007 May;16(5):474-86. doi: 10.1002/pon.1084.
We evaluated the helpfulness of informational, emotional, and decision-making support received by women newly diagnosed with breast cancer from their family, friends, and health care providers. Data were collected at two time points via patient surveys: baseline on an average 2 months post-diagnosis and follow-up at 5 months post-baseline. In the period closer to diagnosis, majority of the women received helpful informational support from health care providers (84.0%); helpful emotional support from family (85%), friends (80.4%), and providers (67.1%); and helpful decision-making support from providers (75.2%) and family (71.0%). Emotional support at baseline and emotional and informational support at 5-month follow-up were significantly associated with patients' health-related quality of life and self-efficacy outcomes (p<0.01). Perceived helpfulness of informational, emotional, and decision-making support provided by family, friends, and providers however significantly decreased over time (p<0.001). Cancer patients' desire significant amount of support throughout their cancer journey. Our results show that while patients receive a lot of support during the period closer to diagnosis, receipt of helpful support drops significantly within the first year itself. In order to facilitate cancer patients' adjustment to their illness, efforts need to be made to understand and address their support needs throughout the cancer experience.
我们评估了新诊断出乳腺癌的女性从家人、朋友和医疗服务提供者那里获得的信息支持、情感支持和决策支持的有效性。通过患者调查在两个时间点收集数据:诊断后平均2个月时为基线,基线后5个月时为随访。在更接近诊断的时期,大多数女性从医疗服务提供者那里获得了有效的信息支持(84.0%);从家人(85%)、朋友(80.4%)和医疗服务提供者(67.1%)那里获得了有效的情感支持;从医疗服务提供者(75.2%)和家人(71.0%)那里获得了有效的决策支持。基线时的情感支持以及5个月随访时的情感和信息支持与患者的健康相关生活质量和自我效能结果显著相关(p<0.01)。然而,家人、朋友和医疗服务提供者提供的信息支持、情感支持和决策支持的感知有效性随时间显著下降(p<0.001)。癌症患者在整个抗癌过程中都渴望大量支持。我们的结果表明,虽然患者在更接近诊断的时期获得了很多支持,但在第一年期间,有效支持的接受量显著下降。为了促进癌症患者对疾病的适应,需要努力在整个癌症经历中理解并满足他们的支持需求。